Oxford Instruments Reports Strong 2024/25 Results and Strategic Sale of Quantum Business

The latest announcement is out from Oxford Instruments ( (GB:OXIG) ).

Oxford Instruments reported strong financial results for the 2024/25 fiscal year, with revenue exceeding £500 million for the first time, driven by growth in semiconductor and materials analysis sectors. The company announced the sale of its NanoScience quantum business for £60 million, allowing it to focus on high-growth areas and initiate a £50 million share buyback program, enhancing shareholder value and accelerating progress towards medium-term margin targets.

The most recent analyst rating on (GB:OXIG) stock is a Hold with a £2240.00 price target. To see the full list of analyst forecasts on Oxford Instruments stock, see the GB:OXIG Stock Forecast page.

Spark’s Take on GB:OXIG Stock

According to Spark, TipRanks’ AI Analyst, GB:OXIG is a Neutral.

Oxford Instruments’ overall score is driven by its strong financial health, characterized by consistent revenue growth and robust profitability. However, the bearish technical indicators suggest caution in the short term. The stock is reasonably valued, which supports a moderate overall score.

To see Spark’s full report on GB:OXIG stock, click here.

More about Oxford Instruments

Oxford Instruments is a leading provider of high technology products and systems for industry and research, serving academic and commercial organizations globally. The company specializes in materials analysis, semiconductor, and healthcare & life science sectors, leveraging innovation to drive growth and success. Founded in 1959 as a spin-out from Oxford University, it is now a global, FTSE250 company.

Average Trading Volume: 158,552

Technical Sentiment Signal: Hold

Current Market Cap: £1.1B

See more insights into OXIG stock on TipRanks’ Stock Analysis page.